New White Paper Reveals the Impact of Gray Market on Pharmaceutical Pricing and Market Across the United States and Europe.

Share Article

The Pricentric team explores how secondary markets in the US and parallel imports in Europe create drug shortages and consequently these shortages affect drug distribution and pricing.

Impact of Gray Market on pharmaceutical pricing

White Paper: Impact of Gray Market on pharmaceutical pricing

The Pricentric team explores how secondary markets in the US and parallel imports in Europe create drug shortages and consequently these shortages affect drug distribution and pricing.

While many believe that drug shortages are a think of the past, due to today’s high tech-world, this is not the case at all. A network of secondary wholesalers in the US and parallel imports in Europe are driving shortages and a demand for essential medicines for patients and medical facilities.

The white paper, “The Impact of Gray Market across the United States and Europe” provides insight into:

  • How the gray market is formed and its effects on drug distribution and pricing
  • The effects of the gray market on pharmaceutical manufacturers
  • The risks of the brand and products when goods are repackaged
  • How drug pricing strategies can affect the gray market

Download a complimentary copy of the white paper, “The Impact of Gray Market across the United States and Europe”: http://www.alscg.com/gray_market_pharmaceutical_pricing/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sophie Ferronato
@ALSCG
since: 12/2010
Follow >
Alliance Life Sciences
since: 07/2010
Like >
Visit website